InnoCan Pharma Corporation
INNPD
$12.53
-$0.39-3.02%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.81% | 38.52% | 28.91% | 25.67% | 53.84% |
| Total Receivables | 83.42% | 17.68% | -19.52% | 44.63% | -11.75% |
| Inventory | -2.14% | 13.53% | 89.87% | 103.57% | 87.79% |
| Prepaid Expenses | -77.18% | -89.33% | -80.29% | -53.94% | -50.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 115.00% | 72.26% | 31.93% | -16.67% | 37.25% |
| Total Current Assets | 27.26% | 20.18% | 34.44% | 40.78% | 49.20% |
|
|
|||||
| Total Current Assets | 27.26% | 20.18% | 34.44% | 40.78% | 49.20% |
| Net Property, Plant & Equipment | -18.03% | -16.41% | -16.91% | -11.94% | -14.08% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 26.63% | 19.66% | 33.43% | 39.75% | 47.68% |
|
|
|||||
| Total Accounts Payable | -40.10% | -62.68% | 65.18% | -60.36% | 119.77% |
| Total Accrued Expenses | -- | -- | 3.24% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -54.55% | -- | -- |
| Total Finance Division Other Current Liabilities | -7.14% | -55.08% | -19.58% | 24.93% | 227.87% |
| Total Other Current Liabilities | -7.14% | -55.08% | -19.58% | 24.93% | 227.87% |
| Total Current Liabilities | 10.60% | -39.27% | -11.99% | 12.85% | 205.96% |
|
|
|||||
| Total Current Liabilities | 10.60% | -39.27% | -11.99% | 12.85% | 205.96% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -93.75% | -84.62% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 62.54% | -9.32% | -12.37% | 12.13% | 197.55% |
|
|
|||||
| Common Stock & APIC | 2.43% | 3.13% | 7.80% | 9.46% | 11.83% |
| Retained Earnings | -4.57% | -1.86% | -5.55% | -8.09% | -14.39% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -12.85% | 13.84% | 25.93% | 19.73% | -3.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.85% | 13.84% | 25.93% | 19.73% | -3.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 104.36% | 270.47% | 555.48% | 812.76% | 30,475.00% |
| Total Equity | 10.73% | 46.34% | 60.10% | 54.28% | 20.75% |
|
|
|||||